Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Russia 8832 new cases Wednesday... Trial must be closing soon...
https://www.reuters.com/business/healthcare-pharmaceuticals/russia-reports-8832-new-covid-19-cases-394-deaths-2021-06-02/
Volume still light MM's letting it ride some...
Why would a partner sign on before results? A partner made sense last summer to assist with expediting and sharing the trial costs. At this point Leo is on his own unless he sells the rights to B for royalties... Data will have to blow the doors off... An expensive phase 3 taking another 6 to 8 months will not occur... It's emergency use or shelved like OM/UP/Absssi and K.
How can the data fail now? Would look foolish after many press releases and a virtual showcase in July! Will be interesting to see how the 2 employee biotech proceeds after results.
This stock rallied to almost 5 bucks 7 years ago and recently traded above 50 pennies 3 times. Those naked shorts had no effect then? How about the CEO deliver something of substance instead of 60 COVID press releases? Judgement day fast approaching!
Pfizer have their own therapeutic for CV19
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-initiates-phase-1-study-novel-oral-antiviral
Russia single day cases continue to climb. https://finance.yahoo.com/news/russia-reports-highest-number-daily-080000320.html
Putin not making vaccines mandatory... Maybe Leo has a Russian partner lined up for emergency use...
https://www.cnbc.com/2021/05/27/russia-covid-vaccines-wont-be-compulsory-putin-says-amid-skepticism.html
Despite pleas from the president and other high-profile officials and the installation of walk-in vaccination centers in shopping malls in big cities, Russia has found that much of its population is reluctant to receive a Covid shot.
Moscow Mayor Sergei Sobyanin has openly vented his frustration at the slow response to vaccinations.
“It is remarkable. ... People are getting sick, they continue to get sick, they continue to die. And yet they still don’t want to get vaccinated,” Sobyanin said
Not enough volume to break the sellers today... Need 2 million share days to move this up to .25...
Correct, it's feast or famine... Don't see a price rally over a dollar unless they get emergency use... An expensive long phase 3 will not be a quick reward and might not even take place without a partner... Only EU will draw partners in... Poor results and its game over... Leo can preach all he wants about other projects but those other projects have been dead for 16 months. Good luck raising capital with a stock price hovering zero. The only reason Kips and Aspire signed on was B for C... Who knows the status of Aspire's millions?
The all-time high market cap was around 600 million. Currently sitting around 90 million shows how much confidence has eroded in 7 years. One person in charge should take responsibility as once a young biotech is relying on good data so the assets can be sold.... There's no company build with 3 employees... It's good data leading to sale or fold-the-tent... Hoping for a sale above .50 but not expecting much more...
We need a George's "IPIX is worth 40 billion" post!!! Going to see some wild market cap/PPS predictions soon mostly outrageous and define logic.
If they all know there will be a 100 percent gain before data release shouldn't the volume be greater? Also, it's not a given the stock will rally before... OM and Prurisol pre-data the stock was flat to down....
Results should take a minimum of 5 weeks after last subject is dosed... The key being data lock? Is it locked after the 29 day post assessment for last patient or locked after dosage?
How did he over deliver? 100 percent enrollment second week of June, another month for the last subjects to have 29 days post observation for data.... Results mid to late July... 7 months for a 120 patient trial... How long for a phase 3? Let's hope they get EU...
Leo should have skipped all the enrollment PRs... Isn't the goal to prevent manipulation ahead of an event? Leo should not even PR data lock, just release data when it's known... We're on track for data release in August was all that was needed 2 months ago...
Kips cashing in the chips, they have 20 million to dump by data release... Leo will keep all his sellers updated with many press releases so they'll know exactly how much time they have left... Enrollment just reached 95 percent Kips!!!
CDEL appears to be the market maker most behind large blocks. My guess it's Kips offloading shares ahead of late July results....
Company? You mean one person operation... IPIX is a far cry from a company... Only reason Leo threw carrots in about other projects was for lawsuits in case the numbers miss bad.... 60 press releases "most touting" B for C is a recipe for many if data misses. CYDY have a bunch now... Leo's PR "corporate update" occurred a few days after CYDY's lawsuits hit the wire how convenient...
Bid .206, ask .22, never trust the earlier MM actions...
Yes, I mentioned the error on a later post...
Cmon Kips take it easy on the ask... Don't get greedy volume is not that great.
If today's PR was announced in Dec the stock would be over a buck... Amazing how successful vaccines and now being almost June have cooled down excitement for many of the CV19 plays... Moderna is one of a few who had success all the way through.
He's been more cautious this time referencing the need for therapeutics. The success of the vaccines have tempered his usual excitement. The only chance for success is someone buys them out or they get emergency use... Phase 3 has not been mentioned at all by King Leo...
Not much excitement today... Leo scoreboard watching at 90 percent couldn't wait 2 more weeks for 100... Gives Kips and others an exit strategy with the continued baby step announcements.
1.4 million shares is the debate... What was the price of CTIX stock when the deal closed?
That's 10,311 shares not million....
My error 1.4 million shares not value. Forgetting the stock used to trade above a buck back in those days.
Have to give Leo credit for the Polymedix deal saved them from certain death last year... And whomever thought to try B for C... Caught most by surprise...
3.5 million for Polymedix assets...
http://www.ipharminc.com/press-release/2016/11/16/cellceutix-acquires-polymedix-assets-from-bankruptcy-court-gains-ownership-of-two-clinical-stage-drugs-multiple-compounds-and-equipment-assets
The purchase price was $2.1 million in cash and 1.4 million shares of CTIX stock.
Less than two years ago, PolyMedix had 28 employees, a market capitalization of $227.4 million and was rated as “outperform” by a well-known investment banking firm.
Nailed today's PR yesterday...
Post # of 360540
Russia highest death total since March. 39 in St Petersburg, maybe the trial will be fully recruited in a couple of weeks? https://tass.com/society/1294041
Data Lock early July... Results mid July, 2 weeks ahead of schedule.
You people don't understand... If one partners that means even less profits for each. If phase 3 costs 30 to 40 million that completes in 6 to 9 months how will anyone know if they can recover those costs and assume P3 will pass? Why a buyout of IPIX makes more sense. IPIX has no structure in place to trust unless they receive a minimum royalty like their other bad deals. Emergency use will be the main driving factor for share appreciation. A phase 3 required will hardly move the needle.
Why would anyone partner this late? B could have been pushed months ago with the trial completed. Again, there's no money to be made with one company let alone 2 involved. It's clear as day why this sold off from .65 and could not hold .50 3 times. Maybe Leo can sell IPIX for 50 to .75 with good data? He's surely not hiring anyone for expansion plans... 2 or 3 employees is a joke...
There's no money to be made with B for C unless it gets emergency use. Will take 9 to 12 months to run an expensive P3... The costs to run will be greater than potential sales in mid 2022 at the earliest. The US will soon have little need for B... The vaccines have done their job.The 20 cent question is? Will 120 subjects be enough to grant EU?
Russia highest death total since March. 39 in St Petersburg, maybe the trial will be fully recruited in a couple of weeks? https://tass.com/society/1294041
Never a follow-up or mention... Another project buried in-the-sand... Still waiting for Leo to mention phase 3 plans or emergency use? What's the point in conducting a P2 trial?
Correct, taken 8 months to run 120 for phase 2... So how many sites will they need for 1K or more? 50 minimum to complete by spring 2022...
There will be no Phase 3, it's emergency use or shelved... There's no point in running a 1K subject trial that will take 6 to 12 months to complete... Also. who pays? The ROI will not be worth the time....
Leo could of had interim data by now for 60 subjects... US is already in full recovery... Wouldn't you want to know data ASAP? String it out further is the IPIX way!!!